Literature DB >> 26074390

Case of H syndrome with massive skin involvement, retroperitoneal fibrosis and Raynaud's phenomenon with a novel mutation in the SLC29A3 gene.

Etsuko Fujita1, Mayumi Komine1, Hidetoshi Tsuda1, Akimasa Adachi1, Satoru Murata1, Yasuyuki Kamata2, Seiji Minota2, Mamitaro Ohtsuki1.   

Abstract

We describe a case of H syndrome with massive skin involvement, retroperitoneal fibrosis and Raynaud's phenomenon. A 48-year-old man with parents of a consanguineous marriage, first appeared with decreased urine output, skin sclerosis on his inner thighs and short stature (142 cm, 47 kg). The patient had suffered from hearing loss since the age of 1 year, and his secondary sexual characteristics had not developed. Computed tomography showed periaortic fibrosis, bilateral ureteral stenosis, hydronephrosis and sclerosis of the germinal cords. A biopsy from the retroperitoneal mass revealed remarkable fibrosis with chronic inflammatory cells. Biopsies from the skin lesion showed thick collagen bundles through the dermis and lymphohistiocytic infiltration with numerous plasma cells. Serum inflammatory markers, such as C-reactive protein, vascular endothelial factor, transforming growth factor-β and soluble interleukin-2 receptor, were elevated. Prednisolone was effective in treating skin lesions and in lowering serum inflammatory markers. After a long period of follow up, genomic DNA of the patient was obtained, and we identified a homozygous mutation in exon 5, c.625G>A, which caused transition of glycine to arginine, p.Gly208Arg, in the patient, but not in DNA samples from another 50 healthy individuals. This is the first case of H syndrome with Raynaud's phenomenon and retroperitoneal fibrosis, and the first Japanese case of H syndrome reported in the English published work with a novel mutation in the SLC29A3 gene.
© 2015 Japanese Dermatological Association.

Entities:  

Keywords:  H syndrome; Raynaud's phenomenon; SLC29A3; multifocal fibrosis; retroperitoneal fibrosis

Mesh:

Substances:

Year:  2015        PMID: 26074390     DOI: 10.1111/1346-8138.12973

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  5 in total

1.  A Case of SLC29A3 Spectrum Disorder-Unresponsive to Multiple Immunomodulatory Therapies.

Authors:  Anoop Mistry; David Parry; Bipin Matthews; Philip Laws; Mark Goodfield; Sinisa Savic
Journal:  J Clin Immunol       Date:  2016-05-23       Impact factor: 8.317

2.  The contribution of the immune system to genitourinary fibrosis.

Authors:  Karen M Doersch; Daniel Barnett; Abbie Chase; Daniel Johnston; J Scott Gabrielsen
Journal:  Exp Biol Med (Maywood)       Date:  2022-05-07

3.  H syndrome: 5 new cases from the United States with novel features and responses to therapy.

Authors:  Jessica L Bloom; Clara Lin; Lisa Imundo; Stephen Guthery; Shelly Stepenaskie; Csaba Galambos; Amy Lowichik; John F Bohnsack
Journal:  Pediatr Rheumatol Online J       Date:  2017-10-17       Impact factor: 3.054

4.  Phenotypic intrafamilial variability including H syndrome and Rosai-Dorfman disease associated with the same c.1088G > A mutation in the SLC29A3 gene.

Authors:  Hamza Chouk; Mohamed Ben Rejeb; Lobna Boussofara; Haїfa Elmabrouk; Najet Ghariani; Badreddine Sriha; Ali Saad; Dorra H'Mida; Mohamed Denguezli
Journal:  Hum Genomics       Date:  2021-10-17       Impact factor: 4.639

Review 5.  Review of the current literature on H syndrome treatment.

Authors:  Kimia Saleh Anaraki; Sepehr Khosravi; Elham Behrangi; Afsaneh Sadeghzadeh-Bazargan; Azadeh Goodarzi
Journal:  J Family Med Prim Care       Date:  2022-03-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.